Skip to main content

Peer Review reports

From: An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma

Original Submission
1 Apr 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
30 Jul 2016 Editorially accepted
11 Aug 2016 Article published 10.1186/s12885-016-2656-8

You can find further information about peer review here.

Back to article page